Akèy › Skleroz Amiotrofik Lateral
Etid klinik pou Skleroz Amiotrofik Lateral ap rekrite nan Etazini
69 etid pou Skleroz Amiotrofik Lateral ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA19 etid
- Philadelphia, PA14 etid
- Baltimore, MD13 etid
- Jacksonville, FL13 etid
- New York City, NY11 etid
- Chicago, IL10 etid
- San Diego, CA10 etid
- San Francisco, CA10 etid
- St. Louis, MO9 etid
- Atlanta, GA8 etid
- Phoenix, AZ8 etid
- Seattle, WA7 etid
- Houston, TX7 etid
- Ann Arbor, MI7 etid
- Dallas, TX7 etid
- Miami, FL7 etid
- Durham, NC7 etid
- Washington, DC6 etid
- Minneapolis, MN6 etid
- Mountain View, CA5 etid
- Los Angeles, CA5 etid
- Birmingham, AL5 etid
- Davie, FL4 etid
- Tampa, FL4 etid
- Aurora, CO4 etid
- Portland, OR4 etid
- Richmond, VA4 etid
- Detroit, MI4 etid
- Gainesville, FL4 etid
- Columbus, OH4 etid
- Salt Lake City, UT4 etid
- Winston-Salem, NC3 etid
- Sacramento, CA3 etid
- Columbia, MO3 etid
- Lincoln, NE3 etid
- Pittsburgh, PA3 etid
- Omaha, NE3 etid
- Harrisburg, PA3 etid
- Hartford, CT3 etid
- Indianapolis, IN3 etid
Pa eta
- Alabama5 etid
- Arizona10 etid
- Colorado5 etid
- Connecticut4 etid
- Distrik Columbia4 etid
- Florid27 etid
- Georgia8 etid
- Illinois11 etid
- Indiana3 etid
- Kalifòni23 etid
- Kansas4 etid
- Maryland15 etid
- Massachusetts23 etid
- Michigan9 etid
- Minnesota8 etid
- Missouri12 etid
- Nebraska6 etid
- New Hampshire3 etid
- New York12 etid
- North Carolina9 etid
- Ohio6 etid
- Oregon4 etid
- Pennsylvania19 etid
- Tennessee4 etid
- Texas13 etid
- Utah6 etid
- Virginia6 etid
- Washington7 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
RAPA-501 Therapy for ALS
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT04220190Developing New Ways to Detect Respiratory Impairment Early in ALS
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07844590A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Ap rekriteFaz 1
Laj 18 a 79 · Tout sèks · Mizajou Sep 23, 2026 · NCT07290062Using Gaze to Enable Head-neck Movements in Patients With Head Drop
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07836751Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07322003Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Sep 17, 2026 · NCT03225144Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07823101RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT06649955Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07287397Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis
Ap rekriteFaz 1 bonè
Laj 18 a 80 · Tout sèks · Mizajou Sep 9, 2026 · NCT07224269Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07521930Biofluid Research on Age-Related or Inherited Neurodegeneration
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07798700Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07023835Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT05474235ASSESS ALL ALS Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06578195PREVENT ALL ALS Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06581861Investigation on the Cortical Communication (CortiCom) System
Ap rekrite
Laj 22 a 70 · Tout sèks · Mizajou Aug 21, 2026 · NCT03567213Tongue-strengthening Exercises in People With ALS.
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Aug 12, 2026 · NCT07295990Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06656702Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications
Ap rekriteVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Aug 7, 2026 · NCT06266403Study of COYA 302 for the Treatment of ALS
Ap rekriteFaz 2/3
Laj 18 a 80 · Tout sèks · Mizajou Aug 6, 2026 · NCT07161999Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT06609213Multicenter ALS Imaging Study
Ap rekriteEtid obsèvasyonMande peman pou patisipan yo
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06735014ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04363684Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.